Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company's medical device pro… Read more
Shandong Weigao Group Medical Polymer Company Limited (UK2) - Total Liabilities
Latest total liabilities as of June 2025: €10.45 Billion EUR
Based on the latest financial reports, Shandong Weigao Group Medical Polymer Company Limited (UK2) has total liabilities worth €10.45 Billion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shandong Weigao Group Medical Polymer Company Limited - Total Liabilities Trend (2013–2024)
This chart illustrates how Shandong Weigao Group Medical Polymer Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shandong Weigao Group Medical Polymer Company Limited Competitors by Total Liabilities
The table below lists competitors of Shandong Weigao Group Medical Polymer Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Westone Information Industry Inc
SHE:002268
|
China | CN¥1.35 Billion |
|
Sally Beauty Holdings Inc
NYSE:SBH
|
USA | $2.03 Billion |
|
Fujian Funeng Co Ltd
SHG:600483
|
China | CN¥20.37 Billion |
|
Peker Gayrimenkul Yatirim Ortakligi AS
IS:PEKGY
|
Turkey | TL3.30 Billion |
|
PT Kalbe Farma Tbk
PINK:PTKFF
|
USA | $5.27 Trillion |
|
Killam Apartment Real Estate Investment Trust
TO:KMP-UN
|
Canada | CA$2.44 Billion |
|
Progyny Inc
NASDAQ:PGNY
|
USA | $226.39 Million |
|
Zeon Corporation
PINK:ZEOOY
|
USA | $187.86 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Shandong Weigao Group Medical Polymer Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Weigao Group Medical Polymer Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Weigao Group Medical Polymer Company Limited (2013–2024)
The table below shows the annual total liabilities of Shandong Weigao Group Medical Polymer Company Limited from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €9.42 Billion | -2.68% |
| 2023-12-31 | €9.68 Billion | -0.74% |
| 2022-12-31 | €9.75 Billion | +3.06% |
| 2021-12-31 | €9.46 Billion | +5.64% |
| 2020-12-31 | €8.95 Billion | -4.02% |
| 2019-12-31 | €9.33 Billion | +6.06% |
| 2018-12-31 | €8.80 Billion | +180.24% |
| 2017-12-31 | €3.14 Billion | -11.61% |
| 2016-12-31 | €3.55 Billion | +29.96% |
| 2015-12-31 | €2.73 Billion | +24.74% |
| 2014-12-31 | €2.19 Billion | -1.56% |
| 2013-12-31 | €2.23 Billion | -- |